VARICELLA-ZOSTER MENINGITIS – CASE REPORT

Dilista Piljic, Humera Porobic-Jahic, Medina Mujic

Abstract


Varicella-zoster virus (VZV) belongs to the group of alpha herpesviruses, and causes two epidemiologically and clinically distinct diseases, chickenpox or varicella as the primary VZV infection, while shingles respresents the endogenous reactivation of latent VZV infection, typically occuring in older individuls and rarely in younger ones. This is a case report of a 12-year-old boy who was hospitalized at the Clinic for Infectious Diseases at the University Clinical Center Tuzla, diagnosed with meningitis from February 20, 2023, to March 7, 2023. Cerebrospinal fluid analysis upon admission showed moderate pleocytosis with mild proteinorrhoea and hypoglycorrhoea. Cerebrospinal fluid was also subjected to microbiological analysis, which returned a positive PCR result for varicella-zoster virus. Laboratory findings showed stable parameters of inflammation throughout the hospitalization. Parenteral antiviral therapy (acyclovir ampoules) was initiated upon admission and continued for 14 days. Follow-up cerebrospinal fluid analysis showed significant improvement. The boy was discharged home in a recovered state with recommendations for follow-up tests and examinations. Varicella-zoster meningitis is a rare but serious and potentially life-threatening complication following primary infection with the varicella-zoster virus, particularly in immunocompromised patients with symptoms of CNS involvement.


Keywords


Varicella-zoster virus, meningitis, immunological tests

References


Al- Turab M, Chehadeh W. Varicella infection in Middle East: Prevalence, complications, and vaccination. J Res Med Sci. 2018;23:19.

Gnann JW Jr. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 2022; 186 Suppl 1:S91

Alvarez JC, Alvarez J, Tinoco H et al. Varicella-Zoster Virus Meningitis and Encephalitis: An Understated Cause of Central Nervous System Infections. Cureus 2020; 12(11): e11583

Ciancia S, Crisafi A, Fontana I, De Fanti A, Amarri S, Lughetti L. Encephalitis due to herpes zoster without rash in an immunocompetent 12-year-old girl: case report and review of the literature. BMC Pediatrics 2020; 348

Espiritu R, Rich M. Herpes Zoster Encephalitis: 2 case reports and review of literature. Infectious Diseases in Clinical Practice 2007; 15(4):p 284-288

Frantzidou F, Kamaria F, Dumaidi K, Skoura L, Antoniadis A, Papa A. Aseptic meningitis and encephalitis because of herpesviruses and enteroviruses in an immunocompetent adult population. Eur J Neurol. 2008;15:995–997.

Mirouse A, Sonneville R, Razazi K et al. Neurologic outcome of VZV encephalitis one year after ICU admission: a multicenter cohort study. Annals of Intensive Care 2022; 12:32

DeBiasi RL, Tyler KL. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev. 2004;17:903–925.

Grahn A, Studahl M. Varicella-zoster virus infections of the central nervous system - prognosis, diagnostics and treatment. J Infect. 2015;71:281–293.

Herlin H, Hansen H, Bodilsen B et al. Clinical Infectious Diseases. 2020

Gilden D, Nagel M, Cohrs R, Mahalingam R. Varicella zoster virus in the nervous system. Baird N. F1000Res. 2015;4:1356.

McGill F, Griffiths MJ, Bonnett LJ et al. Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study. Lancet Infect Dis. 2018;18:992–1003.

Calleri G, Libanore V, Corcione S, De Rosa FG, Caramello P. A retrospective study of viral central nervous system infections: relationship amongst aetiology, clinical course and outcome. Infection.2017;1:227- 231.

Takahashi T, Tamura M, Takasu T. Diagnostic value of a “wide-range” quantitative nested real-time PCR assay for varicella zoster virus myelitis.J Med Virol.2013;1:2042–2055.

Bookstaver PB, Mohorn PL, Shah A, Tesh LD, Quidley AM, Kothari R, et al. Management of Viral Central Nervous System Infections: A Primer for Clinicians. J Cent Nerv Syst Dis. 2017;9:1–12

Mpaka M, Karantanas AH, Zakynthinos E. Atypical presentation of varicella-zoster virus encephalitis in an immunocompetent adult. Heart Lung. 2008;37(1):61–6.

Goyal H, Thakkar N, Bagheri F, Srivastava S. Herpes zoster meningitis with multidermatomal rash in an immunocompetent patient. Am J Emerg Med. 2013;31(11):1622

Kangath RV, Lindeman TE, Brust K. Herpes zoster as a cause of viral meningitis in immunocompetent patients. BMJ Case Reports. 2013;2013:bcr2012007575–5.

Chiappini E, Calabri G, Galli L, Salvi G, De Martino M. Varicella-zoster virus acquired at 4 months of age reactivates at 24 months and causes encephalitis. J Pediatr. 2002;140(2):250–1.

Esposito, S, Bosis, S, Pinzani, R, Morlacchi L, Senatore L, Principi N. A case of meningitis due to varicella zoster virus reactivation in an immunocompetent child. Ital J Pediatr 39, 72 (2013)

Yasuda, R, Minami, K, Ogawa, A et al. Herpes zoster and meningitis in an immunocompetent child: a case report. J Med Case Reports 13, 182 (2019)

Oliveira K, Fonseca J, Moreira D, Vila Real M. Varicella-zoster virus meningitis in an immunocompetent paediatric patient. Neurologia (Engl Ed). 2018 Nov-Dec;33(9):623-624

Kimberlin DW, Brady MT, Jackson MA, Long SS. Report oF the Committee on Infectious Diseases. American Academy of Pediatrics; 2015.

Marin M, Meissner H.C, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics. 2008; 122 (3):e744–e751.


Full Text: PDF

DOI: 10.5457/ams.v54i1.742